July 2nd 2024
Serac Healthcare’s 99mTc-maraciclatide, a new radio-labelled tracer, gains FDA Fast Track Designation for its potential to improve non-invasive diagnosis of superficial peritoneal endometriosis in patients aged 16 and older.
23rd Annual International Congress on the Future of Breast Cancer® East
July 19-20, 2024
Register Now!
Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies
View More
4th Annual International Congress on the Future of Women’s Health™
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 2025
View More
Fertility-sparing surgery matches standard surgery in cervical cancer survival
June 27th 2024A recent study reveals that fertility-sparing surgery offers similar survival outcomes to standard surgery for cervical cancer patients with tumors of 4 cm or smaller, potentially expanding treatment options for younger women.
Perinatal depression linked to increased midlife cardiovascular disease risk
June 26th 2024A recent study revealed a 36% increased risk of cardiovascular disease among women with perinatal depression, highlighting the need for incorporating reproductive health assessment into cardiovascular health evaluations.
Integrating HCV screening with breast cancer programs enhances care
June 25th 2024A recent study from France demonstrates that incorporating hepatitis C virus screening into breast cancer programs significantly improves patient engagement and access to effective antiviral treatments among older women.
HPV-16 identified as highest risk for CIN2 progression in women under active surveillance
June 24th 2024A recent study found that women with human papillomavirus -16 undergoing surveillance for cervical intraepithelial neoplasia grade 2 are at the highest risk of progression to more severe cervical lesions.
Study finds lateral episiotomy lowers obstetric anal sphincter injury risk
June 20th 2024A recent study finds that lateral episiotomy is a safe and effective procedure for reducing obstetric anal sphincter injuries in nulliparous women, highlighting its potential benefits during instrumental births.
Maternal distress during COVID-19 linked to reduced neonatal brain volumes
June 20th 2024A recent study found that maternal psychological distress during the COVID-19 pandemic is associated with reduced white matter and other brain volumes in newborns, highlighting potential long-term impacts on child development.
Study finds estrogen therapy underuse after oophorectomy raises health risks
June 19th 2024A recent highlights elevated morbidity and mortality risks in premenopausal women underusing estrogen therapy after oophorectomy, underscoring the critical need for hormone therapy to mitigate adverse health outcomes.
Single-incision sling reported noninferior to retropubic sling in vaginal prolapse repair
June 17th 2024A new study led by Catherine A. Matthews, MD, FACS, FACOG, indicates that single-incision slings are noninferior to retropubic slings for treating stress incontinence in women undergoing vaginal prolapse repair, with slightly better patient satisfaction and fewer serious adverse events.